Journal Home > Volume 1 , Issue 1

Non-tuberculous mycobacteria are a significant cause of pulmonary infections worldwide and can be clinically challenging. Mycobacterium xenopi (M. xenopi) has a low pathogenicity and usually requires immunosuppression or lung diseases. We describe herein a scarce case of pulmonary cavitary disease attributed to M. xenopi in a 57-year-old Caucasian patient with underlying structural lung disease successfully treated with rifampicin, ethambutol, clarithromycin, and amikacin.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 23 June 2021
Revised: 22 September 2021
Accepted: 16 November 2021
Published: 10 January 2022
Issue date: March 2022

Copyright

© The Author(s) 2021. Published by Elsevier Ltd on behalf of Tsinghua University Press.

Acknowledgements

Acknowledgements

The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Return